HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome

Table 1

Correlation between HAVCR1 expression and clinicopathological characteristics of GAC patients.

Characteristics	Expression of HAVCR1		value
	Low	High
Age			0.067
<60	42	57
≥60	111	96
Gender			0.813
Female	56	56
Male	95	97
Grade			0.478
G1+G2	60	54
G3	93	99
Clinical stage			0.359
I+II	74	66
III+IV	79	87
Pathologic-T			0.290
T1+T2	34	42
T3+T4	119	111
Pathologic-N			0.711
N0	49	46
N1	104	107
Pathologic-M			0.644
M0	144	142
M1	9	11
Death			0.002
Yes	49	75
No	104	78

T: tumor status; N: regional lymph node status; M: metastasis status. Significant correlation.